Projects per year
Fingerprint
Dive into the research topics where Joleen M Hubbard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
Association between Survival and Metastatic Site in Mismatch Repair-Deficient Metastatic Colorectal Cancer Treated with First-line Pembrolizumab
Saberzadeh-Ardestani, B., Jones, J. C., Hubbard, J. M., McWilliams, R. R., Halfdanarson, T. R., Shi, Q., Sonbol, M. B., Ticku, J., Jin, Z. & Sinicrope, F. A., Feb 22 2023, In: JAMA Network Open. 6, 2, p. E230400Research output: Contribution to journal › Article › peer-review
Open Access -
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study
Borad, M. J., Bai, L. Y., Richards, D., Mody, K., Hubbard, J., Rha, S. Y., Soong, J., McCormick, D., Tse, E., O'Brien, D., Bayat, A., Ahn, D., Davis, S. L., Park, J. O. & Oh, D. Y., Mar 2023, In: Hepatology. 77, 3, p. 760-773 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A feasibility study of virtual group therapy to improve quality of life of cancer caregivers
Lapid, M. I., Atherton, P. J., Kung, S., Clark, M. M., Sloan, J. A., Whitford, K. J., Hubbard, J. M., Gentry, M. T., Miller, J. J. & Rummans, T. A., 2022, In: Journal of Psychosocial Oncology. 40, 6, p. 854-867 14 p.Research output: Contribution to journal › Article › peer-review
-
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma
Ahn, D. H., Uson Junior, P. L. S., Masci, P., Kosiorek, H., Halfdanarson, T. R., Mody, K., Babiker, H., DeLeon, T., Sonbol, M. B., Gores, G., Smoot, R., Bekaii-Saab, T., Mahipal, A., Mansfield, A., Tran, N. H., Hubbard, J. M. & Borad, M. J., Feb 2022, In: Investigational New Drugs. 40, 1, p. 134-141 8 p.Research output: Contribution to journal › Article › peer-review
-
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology
Warsame, R., Cook, J., Fruth, B., Hubbard, J., Croghan, K., Price, K. A. R., Jatoi, A., Kumar, S., Thompson, C., Buckner, J., Dispenzieri, A., Sloan, J. & Dueck, A. C., Oct 2022, In: Contemporary Clinical Trials Communications. 29, 100964.Research output: Contribution to journal › Article › peer-review
Open Access